Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Revenue of Inari Medical, Inc. (NARI)
Revenue in 2023 (TTM): $493.63 M
According to Inari Medical, Inc.'s latest financial reports the company's current revenue (TTM) is $493.63 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Inari Medical, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $493.63 M | $434.56 M | $7.11 M | $4.25 M | $-1,636,000 |
| 2022 | $383.47 M | $338.97 M | $-18,254,000 | $-26,185,000 | $-29,267,000 |
| 2021 | $276.98 M | $252.23 M | $15.51 M | $10.69 M | $9.84 M |
| 2020 | $139.67 M | $126.56 M | $16.41 M | $13.79 M | $13.79 M |
| 2019 | $51.13 M | $45.22 M | $358.15 K | $-1,191,825 | $-1,907,118 |
| 2018 | $6.83 M | $5.55 M | $-8,982,465 | $-10,153,000 | $-10,153,000 |